| "As pharmaceutical excipients on drug quality and | | | | as complex, difficult to implement registration |
| safety is important, drug regulatory departments in | | | | management. In addition, the implementation of |
| China have been imposed registration and | | | | administrative examination and approval system for |
| management, registration management of the | | | | registration costs. |
| Pharmaceutical Excipients play a strict supervision of | | | | For the establishment of a scientific and effective |
| the industry, an important role in normal development, | | | | system of medical material management, the National |
| but there are some, such as high cost and other | | | | Bureau in recent years, drawing on experiences of |
| drawbacks of the executive. "few days ago by the | | | | developed countries, based on the attempt to establish, |
| Pharmaceutical and Biological Products of China | | | | promote and improve the practice of medicine in China |
| organized the" 2009 Auxiliaries and Medical Packaging | | | | for raw materials, management systems registration |
| Quality Control Technologies International Forum ", the | | | | for the record, that DMF system. DMF refers to active |
| State Food and Drug Administration drug registration | | | | pharmaceutical ingredients, excipients, direct contact |
| Secretary, said Zhang Wei, China is exploring the | | | | with drugs Packaging materials And containers, |
| implementation of pharmaceutical excipients in DMF | | | | chemical intermediates manufacturer, in accordance |
| (registration and filing of medicinal raw materials) | | | | with the provisions of the information requirements and |
| management system, the system is expected to | | | | procedures, their production processes, quality |
| strengthen the preparation manufacturer of the raw | | | | standards, process parameters and quality indicators, |
| materials of the audit responsibility to raise the level of | | | | and all other technical information, voluntarily submitted |
| the technical review of the accessories and efficiency. | | | | to the State Food and Drug Administration for drug |
| HC pharmaceutical industry network with map | | | | supervision management and pharmaceutical |
| Accessories in the amount of preparation in many | | | | enterprises in the drug registration process and the |
| types of complicated auxiliary own safety, uniformity | | | | production supervision process technology used |
| of quality accessories, supplies and accessories and | | | | document management system. Zhang described the |
| the interaction between the active components of | | | | drafting of DMF system, since 2002, as China - one of |
| drug interaction between the quality of preparation | | | | Canada Drug Cooperation, the State Council began to |
| was obvious. To this end, the State Board to the State | | | | explore the DMF system, and the establishment of the |
| Department retains the right accessories to implement | | | | drafting group, the group by the technical review, |
| registration management. June 2004 the State Council | | | | regulatory authorities, industry associations, etc. form |
| issued "The State Council approved the project | | | | and involves a wide range. Held every year since the |
| Necessary administrative decision of an administrative | | | | relevant seminars, in-depth study technical issues |
| license" (State Council Decree No. 412), the document | | | | related to DMF. DMF in the international system based |
| legally established practice of pharmaceutical | | | | on the full study, in March last year, the drafting group |
| excipients legitimacy of regulatory approval. In 2005, | | | | completed the first draft of China's DMF system. Last |
| the State Council issued the "Pharmaceutical | | | | November 19 and 28, the drafting group meetings |
| Excipients registration requirements for disclosure of | | | | were held with business representatives to discuss the |
| information", the new Pharmaceutical Excipients, import | | | | work has been completed. DMF system |
| medical supplies, medical accessories have national | | | | On the idea of establishing the time, Zhang said, the |
| standards, national standards have been Hollow | | | | basic framework of the system, management |
| Capsule , Medicinal gelatin capsules with gelatin and | | | | methods and international standard consistent with the |
| supplementary application and re-registration of the six | | | | mode, but also adhere to the voluntary reporting, and is |
| major items of medical supplements standardized | | | | divided into public and private parts, no real review and |
| requirements for disclosure of information. | | | | the implementation of approval holder authorizing the |
| "Through the introduction of registration management, | | | | use of, the principles of change to be updated. |
| China's pharmaceutical industry continues to standard | | | | Management includes Medical Packaging, |
| accessories, and growth of production technology and | | | | pharmaceutical excipients. Managed all the relevant |
| management continuously improve quality standards | | | | information the applicant to the drug regulatory |
| continue to improve, greatly promoted the Medicine | | | | departments to voluntarily register for the record, the |
| Development of the industry. But in practice, there are | | | | open part of the preparation of information for |
| some issues can not be ignored. "Zhang stressed that, | | | | enterprises choose to use raw materials, non-public |
| above all, blurred preparation excipients used in the | | | | part of the information for the drug regulatory |
| audit of corporate responsibility, preparation of | | | | departments in the preparation inspection approval and |
| production enterprises as the main responsibility of the | | | | manufacturers use. DMF system |
| selected excipients not reflected in the approval | | | | On the advantages and objectives, Zhang believes |
| system, preparation companies often evade the | | | | that "the most obvious advantage is to strengthen the |
| responsibility for auxiliary enterprises and the | | | | preparation of raw and auxiliary materials, the use of |
| implementation of approved manufacturing Drug | | | | corporate responsibility." Agents manufacturing |
| Administration departments. Second, the accessories | | | | enterprises should be raw and auxiliary materials |
| manufacturers do not want to detailed technical | | | | selected for the real responsibility principal, agent |
| information to the agent enterprise reporting, and drug | | | | business can be directly referenced DMF file number, |
| departments in the preparation of the review process | | | | so to promote its focus on supplier auditing. In addition, |
| can not perform a detailed review, can only rely on the | | | | DMF system divided into two parts and private parts, |
| approval documents, but not many Pharmaceutical | | | | so that technical information can also prevent leakage, |
| Excipients approval documents. Third, the production | | | | ensure that enterprises provide real technical |
| site inspections and GMP inspections limited to | | | | information. Goal of establishing this system is the first |
| registered API And the preparation of enterprises and | | | | technical review services, to improve the technical |
| the lack of actual production by the extension of | | | | review of the auxiliary level and efficiency. And then |
| auxiliary materials, raw materials, production processes | | | | for the on-site inspection and GMP inspection services, |
| Drug Quality Impact of poor control, poor drug quality | | | | increasing the level of variety as the center of the |
| traceability of responsibility. Fourth, hindered the use of | | | | inspection, to establish the true source and the whole |
| new accessories. Accessories manufacturers mostly | | | | process of monitoring the implementation of a real |
| Chemical industry Enterprise, a small proportion of | | | | system of inspection, improve the controllability and |
| Pharmaceutical Excipients, businesses time and money | | | | traceability. Meanwhile, companies choose to meet the |
| do not want to register a higher cost of declaration, it | | | | requirements for the preparation of raw and auxiliary |
| has been registered for approval of supplementary | | | | materials, services, increasing the company as the |
| material has been used in China is far less than the | | | | core of the main agents of responsibility. |
| accessories. Fifth, the premixed formulation excipients | | | | |